Guillain-Barré syndrome in patients with multiple myeloma: three cases report and literature review

被引:0
作者
Li, Zhichao [1 ]
Huang, Fang [1 ]
Hao, Siguo [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Hematol, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China
关键词
Multiple myeloma; Guillain-Barr & eacute; syndrome; Bortezomib; Case report; Neuropathy; BORTEZOMIB; PHASE-3; LIFE;
D O I
10.1186/s12883-025-04045-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundMultiple myeloma (MM) with Guillain-Barr & eacute; syndrome (GBS) is relatively rare, and the specific mechanism is still unclear. The previous infection, surgery, and medication use may have contributed to the occurrence of GBS. The use of bortezomib in patients with MM can easily lead to peripheral neuropathy, which is similar to the symptoms of GBS, making it challenging to diagnose GBS.Cases presentationThree patients with IgA type MM experienced lower limb weakness during treatment. Combined with lumbar puncture, nerve conduction studies, and other tests, the diagnosis was confirmed as GBS. All three patients had a history of spinal surgery before the onset of GBS, and had been treated with bortezomib which induced peripheral neuropathy. Two of the three patients had a clear history of upper respiratory tract infection before the onset of GBS. After treatment with intravenous immunoglobulin, one patient died and two patients showed improvement in GBS symptoms.ConclusionPatients with MM often have concurrent infections and spinal surgery, which may contribute to the occurrence of GBS. The symptoms of bortezomib-induce peripheral neuropathy overlap with those of GBS, which can easily lead to misdiagnosis or missed diagnosis of GBS. Timely lumbar puncture and nerve conduction studies may help to diagnose GBS and improve the prognosis.
引用
收藏
页数:8
相关论文
共 38 条
[11]   Increased incidence of Guillain-Barre syndrome after surgery [J].
Gensicke, H. ;
Datta, A. N. ;
Dill, P. ;
Schindler, C. ;
Fischer, D. .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (09) :1239-1244
[12]  
Gong QY, 2021, BMC NEUROL, V21, DOI [10.1186/s12883-021-02216-6, 10.1186/s12883-021-02067-1]
[13]  
Gupta S, 2006, HAEMATOL-HEMATOL J, V91, P1001
[14]   GUILLAIN-BARRE-SYNDROME IN NORTHERN CHINA - RELATIONSHIP TO CAMPYLOBACTER-JEJUNI INFECTION AND ANTI-GLYCOLIPID ANTIBODIES [J].
HO, TW ;
MISHU, B ;
LI, CY ;
GAO, CY ;
CORNBLATH, DR ;
GRIFFIN, JW ;
ASBURY, AK ;
BLASER, MJ ;
MCKHANN, GM .
BRAIN, 1995, 118 :597-605
[15]   Intravenous immunoglobulin for Guillain-Barre syndrome [J].
Hughes, Richard A. C. ;
Swan, Anthony V. ;
van Doorn, Pieter A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09)
[16]   Risk factors for respiratory failure in Guillain-Barre syndrome in Bangladesh: a prospective study [J].
Islam, Zhahirul ;
Papri, Nowshin ;
Ara, Gulshan ;
Ishaque, Tanveen ;
Alam, Arafat U. ;
Jahan, Israt ;
Islam, Badrul ;
Mohammad, Quazi D. .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02) :324-332
[17]   The spectrum of antecedent infections in Guillain-Barre syndrome -: A case-control study [J].
Jacobs, BC ;
Rothbarth, PH ;
van der Meché, FGA ;
Herbrink, P ;
Schmitz, PIM ;
de Klerk, MA ;
van Doorn, PA .
NEUROLOGY, 1998, 51 (04) :1110-1115
[18]   REFRACTORY GUILLAIN-BARRÉ SYNDROME IN A PATIENT WITH ASYMPTOMATIC MULTIPLE MYELOMA SUCCESSFULLY TREATED WITH LOW-DOSE RITUXIMAB [J].
Krecak, Ivan ;
Gveric-Krecak, Velka .
ACTA CLINICA CROATICA, 2023, 62 (02) :382-386
[19]  
Lu C, 2024, Clin Lab, V70
[20]  
Malard F, 2024, NAT REV DIS PRIMERS, V10, DOI 10.1038/s41572-024-00529-7